These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1795631)

  • 21. Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein.
    Donis RO; Corapi W; Dubovi EJ
    J Gen Virol; 1988 Jan; 69 ( Pt 1)():77-86. PubMed ID: 2447228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies.
    Besselaar TG; Blackburn NK
    Arch Virol; 1991; 121(1-4):111-24. PubMed ID: 1722089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for the G1 protein of California encephalitis virus in infection in vitro and in vivo.
    Hacker JK; Volkman LE; Hardy JL
    Virology; 1995 Feb; 206(2):945-53. PubMed ID: 7531919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.
    Besselaar TG; Blackburn NK
    Arch Virol; 1992; 125(1-4):239-50. PubMed ID: 1642552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus.
    Conraths FJ; Pauli G; Ludwig H
    Virus Res; 1988 Apr; 10(1):53-63. PubMed ID: 2837013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis.
    Chanas AC; Gould EA; Clegg JC; Varma MG
    J Gen Virol; 1982 Jan; 58 Pt 1():37-46. PubMed ID: 7142968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses.
    Gonzalez-Scarano F; Shope RE; Calisher CH; Nathanson N
    Prog Clin Biol Res; 1983; 123():145-56. PubMed ID: 6191341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies.
    Coutelier JP; Van Snick J
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2097-100. PubMed ID: 3404124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity.
    Wakata A; Kanemoto S; Tang H; Kawabata A; Nishimura M; Jasirwan C; Mahmoud NF; Mori Y
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins.
    Eing BR; Kühn JE; Braun RW
    J Med Virol; 1989 Jan; 27(1):59-65. PubMed ID: 2466100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
    Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
    Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and biological function of La Crosse G1 glycoprotein.
    Kingsford L
    Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342
    [No Abstract]   [Full Text] [Related]  

  • 34. Further characterization of the rabies virus glycoproteins produced by virus-infected and G cDNA-transfected cells using a monoclonal antibody, #1-30-44, which recognizes an acid-sensitive epitope.
    Kankanamge PJ; Irie T; Shoji J; Tochikura TS; Kawai A
    Microbiol Immunol; 2003; 47(5):337-49. PubMed ID: 12825895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
    Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Production of monoclonal antibodies against a wild strain of rabies virus].
    Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
    Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturation of Hantaan virus glycoproteins G1 and G2.
    Antic D; Wright KE; Kang CY
    Virology; 1992 Jul; 189(1):324-8. PubMed ID: 1604818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H; Coulon P; Lafay F; Flamand A
    Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.